London Daily

Focus on the big picture.
Tuesday, Feb 10, 2026

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Despite the Covid pandemic, the NHS is reportedly wasting as much as £568 million yearly on habit-forming drugs like painkillers and sleeping pills that the majority of patients do not need, leading to dangerous addictions.

Doctors in England are unnecessarily pushing dependency-causing opioids, antidepressants and other pills, according to a new study by the Council for Evidence-based Psychiatry (CEP). Researchers found that three in four prescriptions were totally unnecessary in some cases.

The study, published on Tuesday in the journal Addictive Behaviours, revealed that, for many patients, their symptoms were not severe enough to warrant such medication. In other cases, safer options of treatment, such as counselling or less toxic drugs, were not fully explored while there were also instances of patients who were put on the pills for longer than required.

“Money is being wasted at a time when the health service is strapped for cash. The NHS is not taking this problem seriously and many doctors don’t appreciate the extent to which withdrawal from these medicines is a problem,” Dr James Davies, the study’s co-lead author, told the Daily Mail.


Between 2015 and 2018, the study estimated, there was a taxpayer bill of £1.7 billion for prescriptions for antidepressants, opioids, gabapentinoids, benzodiazepines and Z-drugs (sleeping pills). The total costs accounted for the price of the drugs, the average consultation cost (about £33) of seeing a General Practitioner (GP), and dispensing fees.

NHS figures reportedly show that nearly 17 million people a year in the country are getting a prescription for such drugs. The level of waste is so colossal that it could go towards paying the salaries of another 10,000 GPs or 20,000 nurses, according to the Daily Mail, which reported that the Department of Health and Social Care is yet to finalise plans to tackle the issue.

Nearly half the taxpayer money being wasted each year – to the tune of £288 million – goes towards highly addictive opioid painkillers followed by £158 million a year for gabapentinoids. But the researchers, from Roehampton University, Greenwich University and University College London, warn that it is likely the total amount lost is far higher than the “conservative” estimates in the study.

In addition, the study does not account for the significant costs related to harms caused by habit-forming drugs. These include higher disability payments and lost tax revenues, as well as workplace absenteeism and decreased productivity.

Besides the financial losses, unnecessary prescription also exacts a human cost: when people try to kick the habit, they suffer severe withdrawal symptoms, including stomach cramps, blurred vision and loss of appetite. For instance, studies on benzodiazepine usage reportedly show that 50% of those on the drugs for as little as four weeks suffer anxiety, dizziness, concentration problems, nightmares and weakness. That figure rises to 100% for people taking the medication for over six months.

Commenting on the study, Tory MP Danny Kruger, who chairs the All Party Parliamentary Group for Prescribed Drug Dependence, said that a “fraction of these wasted costs should now be invested in a helpline and dedicated withdrawal support services.”

In 2019, a Public Health England report revealed that “hundreds of thousands” of patients had become dependent on medicines and recommended face-to-face support, better training for doctors on the risks of drug dependency, and a 24-hour helpline on how to reduce medication.

While little action has occurred since, a Department of Health and Social Care spokesman told the Daily Mail that ministers are finally backing plans for a helpline and will be “working closely” with the NHS to implement the recommendations.

Newsletter

Related Articles

0:00
0:00
Close
UK Police Review Fresh Claims Involving Prince Andrew as Senior Royals Respond to Epstein Files
Keir Starmer’s Premiership Faces Unprecedented Strain as Epstein Fallout Deepens
Starmer Vows to Stay in Office as UK Government Faces Turmoil After Epstein Fallout
China and UK Signal Tentative Reset with Commitment to Steadier, Professionally Managed Relations
UK Confirms Imminent Increase in ETA Fee to £20 as Entry Rules Tighten
UK Signals Possible Seizure of Russia-Linked ‘Shadow Fleet’ Tanker in Escalation of Sanctions Enforcement
Epstein Scandal Piles Unprecedented Pressure on UK Prime Minister Keir Starmer’s Leadership
UK’s ‘Most Romantic Village’ Celebrates Valentine’s Day and Explores the Festival’s Rich History
The Implications of Expanding Voting Rights to Non-EU Foreign Residents in France
Ghislaine Maxwell to Testify Before US Congress on February 9
Al.com Acquired by Crypto.com Founder for $70 Million
Apple iPhone Lockdown Mode blocks FBI data access in journalist device seizure
Belgium: Man Charged with Rape After Faking Payment to Sex Worker
KPMG Urges Auditor to Relay AI Cost Savings
US and Iran to Begin Nuclear Talks in Oman
Winklevoss-Led Gemini to Slash a Quarter of Jobs and Exit European and Australian Markets
Canada Opens First Consulate in Greenland Amid Rising Geopolitical Tensions
China unveils plans for a 'Death Star' capable of launching missile strikes from space
NASA allows astronauts to take smartphones on upcoming missions to capture special moments.
Trump administration to launch TrumpRx.gov for direct drug purchases
Investigation Launched at Winter Olympics Over Ski Jumpers Injecting Hyaluronic Acid
U.S. State Department Issues Urgent Travel Warning for Citizens to Leave Iran Immediately
Wall Street Erases All Gains of 2026; Bitcoin Plummets 14% to $63,000
Epstein Case Documents Reignite Global Scrutiny of Political and Business Elites
Eighty-one-year-old man in the United States fatally shoots Uber driver after scam threat
UK Royal Family Faces Intensifying Strain as Epstein-Linked Revelations Rock the Institution
Political Censorship: French Prosecutors Raid Musk’s X Offices in Paris
AI Invented “Hot Springs” — Tourists Arrived and Were Shocked
Tech Mega-Donors Power Trump-Aligned Fundraising Surge to $429 Million Ahead of 2026 Midterms
UK Pharma Watchdog Rules Sanofi Breached Industry Code With RSV Vaccine Claims Against Pfizer
Melania Documentary Opens Modestly in UK with Mixed Global Box Office Performance
Starmer Arrives in Shanghai to Promote British Trade and Investment
Harry Styles, Anthony Joshua and Premier League Stars Among UK’s Top Taxpayers
New Epstein Files Include Images of Former Prince Andrew Kneeling Over Unidentified Woman
Starmer Urges Former Prince Andrew to Testify Before US Congress About Epstein Ties
Starmer Extends Invitation to Japan’s Prime Minister After Strategic Tokyo Talks
Skupski and Harrison Clinch Australian Open Men’s Doubles Title in Melbourne
DOJ Unveils Millions of Epstein Files, Fueling Global Scrutiny of Elite Networks
France Begins Phasing Out Zoom and Microsoft Teams to Advance Digital Sovereignty
China Lifts Sanctions on British MPs and Peers After Starmer Xi Talks in Beijing
Trump Nominates Kevin Warsh as Fed Chair to Reorient U.S. Monetary Policy Toward Pro-Growth Interest Rates
AstraZeneca Announces £11bn China Investment After Scaling Back UK Expansion Plans
Starmer and Xi Forge Warming UK-China Ties in Beijing Amid Strategic Reset
Tech Market Shifts and AI Investment Surge Drive Global Innovation and Layoffs
Markets Jolt as AI Spending, US Policy Shifts, and Global Security Moves Drive New Volatility
U.S. Signals Potential Decertification of Canadian Aircraft as Bilateral Tensions Escalate
Former South Korean First Lady Kim Keon Hee Sentenced to 20 Months for Bribery
Tesla Ends Model S and X Production and Sends $2 Billion to xAI as 2025 Revenue Declines
China Executes 11 Members of the Ming Clan in Cross-Border Scam Case Linked to Myanmar’s Lawkai
Trump Administration Officials Held Talks With Group Advocating Alberta’s Independence
×